Robert Ticktin

Filings by Robert Ticktin span 2 companies, the busiest being EPIRUS Biopharmaceuticals, Inc. and PMV Pharmaceuticals, Inc. The record holds 3 filings, for trades running from 27 February 2016 to 1 July 2025.

The open-market record consists of 1 sale worth €21k, with no purchase. Outside the open market, there are 2 option exercises. 2025 to date brings no purchases and 1 sale.

Most recently, on 3 July 2025, the filings show an open-market sale worth €21k in PMV Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.